Li Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Zhang has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Xiangyu Chen
Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China; Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai, Guangdong 519087, China
5 shared publicationsYanan Zhang
Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, China
5 shared publicationsDanping Huang
Department of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China
4 shared publicationsNan Xiao
Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China; Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai, Guangdong 519087, China
4 shared publicationsXiaodie Chen
Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China; Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai, Guangdong 519087, China
4 shared publications- Zunpeng Shu
Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai 519087, China
4 shared publications
Latest Publications
- 15 April 2026
- Published by Elsevier in Phytomedicine
- Vol. 156, 158183
Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis
- 15 April 2026
- Published by Elsevier in Phytomedicine
- Vol. 156, 158183
Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis
- Top Cited PapersOpen Access
- 25 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program
The gut microbiota plays a crucial role in maintaining intestinal stem cell (ISC) homeostasis and epithelial barrier integrity. Here, we report that Blautia coccoides (B. coccoides) is significantly reduced in inflammatory bowel disease (IBD) patients and dextran sulfate sodium (DSS)-induced colitis mice. Through an integrated approach combining RNA sequencing, metabolomic profiling, and ISC lineage tracing across multiple mucosal injury models, we demonstrate that B. coccoides colonization enhances β-hydroxybutyrate (BHB) production in intestinal epithelial cells (IECs), which activates HOPX⁺ reserve ISCs and promotes regeneration of the LGR5⁺ ISC pool, thereby accelerating epithelial repair. We further show that B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis. Using an engineered Escherichia coli strain expressing BC-derived phenyllactate dehydrogenase (fldH), we establish that both dietary Trp and bacterial fldH activity are essential for ILA/IPA generation and subsequent mucosal healing. Our findings reveal a microbiota-metabolite-ISC regulatory axis critical for epithelial regeneration and propose novel metabolite-based therapeutic strategies for IBD and other intestinal disorders associated with barrier dysfunction.
- 25 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Top Cited PapersOpen AccessA microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program
The gut microbiota plays a crucial role in maintaining intestinal stem cell (ISC) homeostasis and epithelial barrier integrity. Here, we report that Blautia coccoides (B. coccoides) is significantly reduced in inflammatory bowel disease (IBD) patients and dextran sulfate sodium (DSS)-induced colitis mice. Through an integrated approach combining RNA sequencing, metabolomic profiling, and ISC lineage tracing across multiple mucosal injury models, we demonstrate that B. coccoides colonization enhances β-hydroxybutyrate (BHB) production in intestinal epithelial cells (IECs), which activates HOPX⁺ reserve ISCs and promotes regeneration of the LGR5⁺ ISC pool, thereby accelerating epithelial repair. We further show that B. coccoides-derived indole-3-lactic acid (ILA), a tryptophan (Trp) metabolite, is converted into indole-3-propionic acid (IPA) by commensal bacteria such as P. russellii or C. sporogenes, stimulating IEC BHB synthesis. Using an engineered Escherichia coli strain expressing BC-derived phenyllactate dehydrogenase (fldH), we establish that both dietary Trp and bacterial fldH activity are essential for ILA/IPA generation and subsequent mucosal healing. Our findings reveal a microbiota-metabolite-ISC regulatory axis critical for epithelial regeneration and propose novel metabolite-based therapeutic strategies for IBD and other intestinal disorders associated with barrier dysfunction.
- Open Access
- 6 February 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 362, 121315
Buyang Huanwu Decoction attenuates vascular aging by suppressing the pathway of neutrophil extracellular trap formation via modulation of the HMGB1/TLR4/p38 signaling pathway
- 6 February 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 362, 121315
Open AccessBuyang Huanwu Decoction attenuates vascular aging by suppressing the pathway of neutrophil extracellular trap formation via modulation of the HMGB1/TLR4/p38 signaling pathway
- 22 December 2025
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 27 (1) , 1-4
Commensal bacteria play a fundamental role in maintaining gut immune homeostasis
摘要 肠道中种类庞杂的微生物群落统称为肠道菌群, 其与宿主间相互影响, 形成了复杂的共生体系统。肠道菌群与动物健康关系密切, 具有消化、合成维生素以及合成其他重要代谢物和神经递质的功能。多项研究表明, 菌群相关代谢产物可通过直接或间接方式调节宿主的生理功能和免疫反应, 以维持局部及全身的稳态平衡。我们利用葡聚糖硫酸钠诱导的结肠炎小鼠模型证实, 肠道共生细菌纽约杜伯氏菌及其人类同源菌无害梭菌, 可通过产生短链脂肪酸 (特别是丙酸) 和赖氨酸调节免疫耐受, 从而缓解结肠炎。赖氨酸可通过芳烃受体激活树突状细胞中的吲哚胺2,3-双加氧酶1 (IDO1), 诱导调节性T淋巴细胞 (Treg) 产生免疫抑制的肠道微环境, 该研究可为炎症性肠病提供一种潜在的治疗策略。
- 22 December 2025
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 27 (1) , 1-4
Commensal bacteria play a fundamental role in maintaining gut immune homeostasis
摘要 肠道中种类庞杂的微生物群落统称为肠道菌群, 其与宿主间相互影响, 形成了复杂的共生体系统。肠道菌群与动物健康关系密切, 具有消化、合成维生素以及合成其他重要代谢物和神经递质的功能。多项研究表明, 菌群相关代谢产物可通过直接或间接方式调节宿主的生理功能和免疫反应, 以维持局部及全身的稳态平衡。我们利用葡聚糖硫酸钠诱导的结肠炎小鼠模型证实, 肠道共生细菌纽约杜伯氏菌及其人类同源菌无害梭菌, 可通过产生短链脂肪酸 (特别是丙酸) 和赖氨酸调节免疫耐受, 从而缓解结肠炎。赖氨酸可通过芳烃受体激活树突状细胞中的吲哚胺2,3-双加氧酶1 (IDO1), 诱导调节性T淋巴细胞 (Treg) 产生免疫抑制的肠道微环境, 该研究可为炎症性肠病提供一种潜在的治疗策略。
- 17 September 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355 (Pt A) , 120624
Elucidation of the potential molecular mechanisms of Buyang Huanwu Decoction in delaying cardiac aging: Based on network pharmacology, bioinformatics, and in vivo/in vitro experimental validation
- 17 September 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355 (Pt A) , 120624
Elucidation of the potential molecular mechanisms of Buyang Huanwu Decoction in delaying cardiac aging: Based on network pharmacology, bioinformatics, and in vivo/in vitro experimental validation
- Open Access
- 1 September 2025
- Published by KEAI Publishing in Journal of Holistic Integrative Pharmacy
- Vol. 6 (3) , 276-289
Integrative network pharmacology and transcriptomics suggest the mechanism of Buyang Huanwu Decoction in attenuating vascular aging via AMPK signaling pathway
- 1 September 2025
- Published by KEAI Publishing in Journal of Holistic Integrative Pharmacy
- Vol. 6 (3) , 276-289
Open AccessIntegrative network pharmacology and transcriptomics suggest the mechanism of Buyang Huanwu Decoction in attenuating vascular aging via AMPK signaling pathway
- 20 June 2025
- Vol. 45 (6) , 1251-1259
[Buyang Huanwu Decoction delays vascular aging in rats through exosomal miR-590-5p signal-mediated macrophage polarization].
To investigate the mechanism underlying the inhibitory effect of Buyang Huanwu Decoction (BYHWD) on vascular aging. Eighteen male SD rats were randomized into young group, intraperitoneal D-galactose injection-induced aging group, and BYHWD gavage group. The changes in pulse wave velocity (PWV), vascular SA-β-gal activity, and expressions of p16, p21 and SA‑β‑gal of the rats were examined. Serum exosomes were isolated from the rats, and after characterization using NTA and TEM and for surface markers and vascular cell markers, were examined for miR-590-5p expression using qRT-PCR. The M1/M2 macrophage ratio and cytokine levels were evaluated using immunofluorescence staining and qRT-PCR. Bioinformatics analysis and dual-luciferase reporter assays were carried out to predict the potential target genes of miR-590-5p and validate its targeting relationship with SLC8A3, whose expressions were detected in the vascular tissues of the rats by Western blotting. Compared with the young rats, the aging rats exhibited significantly increased PWV in the abdominal aorta with elevated vascular expressions of p16, p21 and SA-β-gal, which were all reversed by BYHWD treatment. The isolated serum exosomes were positive for CD63, CD81, CD31 and SM-22, and the exosomes from aging rats showed significantly downregulated expression of miR-590-5p, which was upregulated after BYHWD treatment. The aging rat vessels showed an increased M1/M2 macrophage ratio with elevated M1-specific cytokines and reduced M2-specific cytokines, and BYHWD treatment effectively inhibited M1 polarization of the macrophages. Pearson analysis revealed a negative correlation between exosomal miR-590-5p upregulation and the M1/M2 ratio. Bioinformatics analysis and dual-luciferase assays confirmed that miR-590-5p targets SLC8A3. Western blotting demonstrated increased SLC8A3 expression in aging rat vessels, which was downregulated after BYHWD treatment. BYHWD attenuates vascular aging in rats by modulating macrophage M1 polarization and suppressing vascular inflammation via exosomal miR-590-5p-mediated downregulation of SLC8A3.
- 20 June 2025
- Vol. 45 (6) , 1251-1259
[Buyang Huanwu Decoction delays vascular aging in rats through exosomal miR-590-5p signal-mediated macrophage polarization].
To investigate the mechanism underlying the inhibitory effect of Buyang Huanwu Decoction (BYHWD) on vascular aging. Eighteen male SD rats were randomized into young group, intraperitoneal D-galactose injection-induced aging group, and BYHWD gavage group. The changes in pulse wave velocity (PWV), vascular SA-β-gal activity, and expressions of p16, p21 and SA‑β‑gal of the rats were examined. Serum exosomes were isolated from the rats, and after characterization using NTA and TEM and for surface markers and vascular cell markers, were examined for miR-590-5p expression using qRT-PCR. The M1/M2 macrophage ratio and cytokine levels were evaluated using immunofluorescence staining and qRT-PCR. Bioinformatics analysis and dual-luciferase reporter assays were carried out to predict the potential target genes of miR-590-5p and validate its targeting relationship with SLC8A3, whose expressions were detected in the vascular tissues of the rats by Western blotting. Compared with the young rats, the aging rats exhibited significantly increased PWV in the abdominal aorta with elevated vascular expressions of p16, p21 and SA-β-gal, which were all reversed by BYHWD treatment. The isolated serum exosomes were positive for CD63, CD81, CD31 and SM-22, and the exosomes from aging rats showed significantly downregulated expression of miR-590-5p, which was upregulated after BYHWD treatment. The aging rat vessels showed an increased M1/M2 macrophage ratio with elevated M1-specific cytokines and reduced M2-specific cytokines, and BYHWD treatment effectively inhibited M1 polarization of the macrophages. Pearson analysis revealed a negative correlation between exosomal miR-590-5p upregulation and the M1/M2 ratio. Bioinformatics analysis and dual-luciferase assays confirmed that miR-590-5p targets SLC8A3. Western blotting demonstrated increased SLC8A3 expression in aging rat vessels, which was downregulated after BYHWD treatment. BYHWD attenuates vascular aging in rats by modulating macrophage M1 polarization and suppressing vascular inflammation via exosomal miR-590-5p-mediated downregulation of SLC8A3.
- 19 September 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118819
Research on the mechanism of buyang huanwu decoction in the amelioration of age-associated memory impairment based on the “co-occurrence network regulation of intestinal microecology-host metabolism-immune function”
- 19 September 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118819
Research on the mechanism of buyang huanwu decoction in the amelioration of age-associated memory impairment based on the “co-occurrence network regulation of intestinal microecology-host metabolism-immune function”
- 1 September 2023
- Published by American Scientific Publishers in Science of Advanced Materials
- Vol. 15 (9) , 1265-1275
Mechanisms of Linggui Zhugan Decoction in the Treatment of Obesity Based on Network Pharmacology
This study employed network pharmacology to investigate how Linggui Zhugan Decoction (LGZGD) may treat obesity. The TCMSP platform was used to select active ingredients and targets of LGZGD based on drug ADME properties, forming a component-target network. Obesity-related targets were identified from various databases, and a global network was constructed to analyze interactions between components, targets, and disease-related proteins. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using G: profiler. Molecular docking using AutoDockTools validated the binding of key active components to core targets. The study identified 120 active ingredients and 201 targets for LGZGD, with 84 targets related to obesity. GO analysis revealed various biological processes, cellular components, and molecular functions associated with obesity, including lipid response and cellular response to chemical stimuli. KEGG pathway analysis highlighted signaling pathways such as AGE-RAGE signaling in diabetic complications, cancer pathways, IL-17 signaling, and neuroactive ligand-receptor interaction signaling. Molecular docking confirmed that the core active components of LGZGD tightly bind to key targets involved in obesity treatment. This study provides a preliminary understanding of the pharmacological basis and efficacy mechanism of LGZGD in treating obesity, supporting its traditional use and offering a theoretical foundation for further research.
- 1 September 2023
- Published by American Scientific Publishers in Science of Advanced Materials
- Vol. 15 (9) , 1265-1275
Mechanisms of Linggui Zhugan Decoction in the Treatment of Obesity Based on Network Pharmacology
This study employed network pharmacology to investigate how Linggui Zhugan Decoction (LGZGD) may treat obesity. The TCMSP platform was used to select active ingredients and targets of LGZGD based on drug ADME properties, forming a component-target network. Obesity-related targets were identified from various databases, and a global network was constructed to analyze interactions between components, targets, and disease-related proteins. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using G: profiler. Molecular docking using AutoDockTools validated the binding of key active components to core targets. The study identified 120 active ingredients and 201 targets for LGZGD, with 84 targets related to obesity. GO analysis revealed various biological processes, cellular components, and molecular functions associated with obesity, including lipid response and cellular response to chemical stimuli. KEGG pathway analysis highlighted signaling pathways such as AGE-RAGE signaling in diabetic complications, cancer pathways, IL-17 signaling, and neuroactive ligand-receptor interaction signaling. Molecular docking confirmed that the core active components of LGZGD tightly bind to key targets involved in obesity treatment. This study provides a preliminary understanding of the pharmacological basis and efficacy mechanism of LGZGD in treating obesity, supporting its traditional use and offering a theoretical foundation for further research.
- Open Access
- 4 August 2022
- Published by Springer Nature in Human Cell
- Vol. 35 (6) , 1684-1696
Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
Astragaloside IV (AS-IV), as one of the main active components of Astragalus membranaceus, has been reported to have cardiovascular protective effects. However, the role and molecular mechanism of AS-IV in vascular senescence have not been clearly stated. The in vitro aging model was constructed using bleomycin (BLM) in vascular smooth muscle cells (VSMCs). Cell senescence were assessed through Western blotting analysis of aging markers, flow cytometry, and the β-galactosidase (SA-β-Gal) kit. Mitophagy was determined through transmission electron microscopy, TMRM staining, and Western blotting analysis of p62. A model of aging blood vessels was induced by d-gal. The vascular wall thickness of mice was also evaluated by H&E staining. Our data proved that AS-IV plays an anti-senescent role in vitro and in vivo. Results showed that AS-IV effectively improved mitochondrial injury, raised MMP, and mediated mitophagy in BLM-induced senescent VSMCs and d-gal induced aging mice. Parkin expression strengthened AS-IV’s anti-senescent function. In conclusions, AS-IV attenuated BLM-induced VSMC senescence via Parkin to regulate mitophagy. Therefore, AS-IV-mediated Parkin might be a latent therapeutic agent and target for VSMC senescence.
- 4 August 2022
- Published by Springer Nature in Human Cell
- Vol. 35 (6) , 1684-1696
Open AccessAstragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy
Astragaloside IV (AS-IV), as one of the main active components of Astragalus membranaceus, has been reported to have cardiovascular protective effects. However, the role and molecular mechanism of AS-IV in vascular senescence have not been clearly stated. The in vitro aging model was constructed using bleomycin (BLM) in vascular smooth muscle cells (VSMCs). Cell senescence were assessed through Western blotting analysis of aging markers, flow cytometry, and the β-galactosidase (SA-β-Gal) kit. Mitophagy was determined through transmission electron microscopy, TMRM staining, and Western blotting analysis of p62. A model of aging blood vessels was induced by d-gal. The vascular wall thickness of mice was also evaluated by H&E staining. Our data proved that AS-IV plays an anti-senescent role in vitro and in vivo. Results showed that AS-IV effectively improved mitochondrial injury, raised MMP, and mediated mitophagy in BLM-induced senescent VSMCs and d-gal induced aging mice. Parkin expression strengthened AS-IV’s anti-senescent function. In conclusions, AS-IV attenuated BLM-induced VSMC senescence via Parkin to regulate mitophagy. Therefore, AS-IV-mediated Parkin might be a latent therapeutic agent and target for VSMC senescence.